Cannabis

Medicinal

Discover the Uruguayan companies exporting Medicinal

Uruguay was the first country in the world to comprehensively regulate cannabis, including its use for medicinal purposes. This early regulation led to the emergence of an industrial ecosystem focused on the development of active ingredients, pharmaceutical formulations, and finished products with therapeutic applications.

More than 100 companies operate in the sector, many of them with vertical models that integrate cultivation, research, industrialization, and distribution.

Competitive advantages

• Solid legal framework that provides legal certainty and predictability. There are specific controls and authorizations for non-psychoactive hemp (low THC content).
• Strategic location with easy access to ports and airports.
• Modern and efficient infrastructure, energy matrix based on renewable sources, and advanced digital connectivity.
• Investment incentives through special regimes and equal treatment for domestic and foreign capital.

Export products

• Dried flowers with high THC or CBD content (medicinal use)
• Active pharmaceutical ingredients (API/IFA)
• Finished medicines
• Extracts and formulations for therapeutic use

Main destinations

Uruguay exports medical cannabis to markets such as Germany, Portugal, and Israel, as well as to countries in the region such as Brazil and Argentina, and also to Spain, Australia, New Zealand, and the Czech Republic.